sábado, 29 de septiembre de 2018

Alnylam, with positive data on second gene-silencing drug, plans filing to FDA

Alnylam, with positive data on second gene-silencing drug, plans filing to FDA

Daily Recap

Alnylam, with positive data on second gene-silencing drug, plans filing to FDA

By ANDREW JOSEPH


LANE TURNER/THE BOSTON GLOBE
The company said it hopes to file with the Food and Drug Administration for accelerated approval of the drug, givosiran, likely by the end of the year.

No hay comentarios:

Publicar un comentario